After a weekend with her SMA community, columnist Brianna Albers faces a difficult truth: Some things are hers to achieve, and some are not.

Molecular markers in cerebrospinal fluid may help predict if people with SMA type 2 or type 3 will respond to treatment with ...

Upgrades to the home of a person with spinal muscular atrophy can ease daily SMA accessibility challenges and support greater ...

A group of questionnaires called PROfuture can meaningfully measure a variety of symptoms of SMA that impact patients, a study reported.

Columnist Connie Chandler shares how traveling with SMA isn't a solo journey, but an opportunity to deepen bonds with people ...

Joanna Buoniconti is a writer and editor based in western Massachusetts. She was diagnosed with SMA type 2 in 2000 at 10 ...

Guest writer Joanna Buoniconti says that new treatments have granted her many things she's grateful for, including the ...

Columnist Sherry Toh discovers that an app's guys can treat her like any other woman — which makes for a lot of potential bad ...